• 802/2, Sampa, Nr. Jaliyamath Railway Station, Dehgam, Gandhinagar

Follow Us:

Business Area

  |  Business Area
Business Area

India (Branded Generics)

Sruzam has risen to prominence in the Indian market during the previous nine years, with a clear focus on fast-growing specialist therapeutic areas. Today, Sruzam holds an excellent position in all key therapeutic segments, including Cardio-Diabetic, Dermatology, Gynecology, and Pain Management, with many of our brands leading their respective sub-therapeutic areas. We have grown faster than the industry in all of these segments.

Europe-Generics

Sruzam Labs is now establishing itself as a significant niche player in the European generics market.
Our aim is to enter the market selectively, offering products with low competition. Currently, we are awaiting EU GMP approval. We intend to file 8-12 products per year.
We continue to collaborate with all of the market’s main distributors, providing outstanding service and solidifying our position as a preferred partner. 

Emerging Markets (Branded Generics)

Our branded generic products are the main source of sales in these markets, where we have established exceptional brand equity.
We are present in many therapeutic areas in emerging markets, including cardiovascular, anti-diabetes, antibiotic, anti-malarial, pain, respiratory, gynecological, pediatric, and general health products.
Our strong product pipeline, which is awaiting regulatory clearance in these markets, will strengthen our positions as market leaders in the therapeutic and sub-therapeutic categories.